News and Announcements
APN Property Group Ltd (ASX:APD) CEO Interview
- Published July 06, 2015 11:01AM UTC
- Publisher Wholesale Investor
- Categories Executive Interviews
APN Property Group Limited (APN) is a specialist real estate investment manager that actively manages real estate funds on behalf of institutional and retail investors.
Established in 1996, APN is listed on the ASX (ASX code: APD) and manages $2.1 billion (as at 31 December 2014) of real estate and real estate securities in 12 funds.
Focused exclusively on real estate funds management and with a core philosophy of “property for income”, we seek to establish and actively manage a suite of real estate funds to provide annuity style income and wealth creation opportunities for retail and institutional investors. This philosophy remains central to APN’s investment offerings across Property Securities, Managed Funds, Private Direct Property Funds and Listed Property Funds.
APN has a longstanding commitment to investment performance and outstanding service. We deliver this through our highly disciplined investment approach, our deep understanding of commercial real estate and our dedicated in-house customer service and registry team.
APN has a market capitalisation of approximately $120 million and delivered a total return to shareholders in excess of 40% over the 12 months to 31 March 2014.
To find out more about APN, please listen to CEO, Mr Michael Doble.
Executive Interviews
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
